NATtrol™ SARS-Related Coronavirus 2 Variant B.1.351 Stock (1mL)

Catalog# NATSARS(COV2-SA)-ST

Product Information:

Volume: 1.0mL
Units/Pack: 1
Storage Condition: 2-8°C
Hazardous Information: Non-Infectious
Matrix: Purified protein matrix treated with 0.09% sodium azide
Target: 1,000,000 copies/mL
Product Type: Inactivated Organism

Classification/ Permits:

RUO
Learn More
For Research Use Only. Not for use in Diagnostic Procedures.
X

Description

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock is formulated with purified, intact viral particles. that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol SARS-CoV-2 Variant B.1.351 stock in a proprietary matrix at the target concentration

Intended Use

NATtrol SARS-CoV-2 Variant B.1.351 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 Variant B.1.351 RNA. NATtrol SARS-CoV-2 Variant B.1.351 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

Documents

Limitations

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES � Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. � This product is not intended to replace the manufacturer�s controls provided with the assay.